End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | -2.54% | -3.36% | -43.63% |
Sales 2024 * | 413M 34.39B | Sales 2025 * | 483M 40.24B | Capitalization | 85.46M 7.12B |
---|---|---|---|---|---|
Net income 2024 * | -50M -4.17B | Net income 2025 * | -36M -3B | EV / Sales 2024 * | 0.21 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.18 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.69% |
Latest transcript on The Oncology Institute, Inc.
1 day | -2.54% | ||
1 week | -3.36% | ||
Current month | -27.22% | ||
1 month | -27.22% | ||
3 months | -46.01% | ||
6 months | -39.15% | ||
Current year | -43.63% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Virnich
CEO | Chief Executive Officer | 46 | 01/19/01 |
Mihir Shah
DFI | Director of Finance/CFO | 45 | 04/22/04 |
Jeremy Castle
COO | Chief Operating Officer | 41 | 05/23/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Barasch
CHM | Chairman | 70 | 12/21/12 |
Mark Pacala
BRD | Director/Board Member | 68 | 21/22/21 |
Bradford Hively
BRD | Director/Board Member | 45 | 01/19/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.15 | -2.54% | 79,351 |
25/24/25 | 1.18 | -1.67% | 58,372 |
24/24/24 | 1.2 | +1.69% | 36,287 |
23/24/23 | 1.18 | +4.42% | 61,406 |
22/24/22 | 1.13 | -5.04% | 111,720 |
End-of-day quote Nasdaq, April 26, 2024
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.63% | 85.46M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+11.62% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- TOI Stock